12.07.2019 • Topicschemistry isArchroma

Chemistry is ... Economical and Ecological

Foron SP-WF, a range of high wet-fast disperse dyes for sportswear and active...
Foron SP-WF, a range of high wet-fast disperse dyes for sportswear and active wear applications © Archroma

Archroma recently launched at the ITMA exhibition its new Foron SP-WF, a range of high wet-fast disperse dyes for sportswear and active wear applications. These are especially suited for the coloration of polyester fibers and microfibers, in exhaustion application. The new product is at the core of Archroma's Fast Sport, a coloration system for polyester knitted sportswear, providing the best fastness in the shortest possible time with a reduced environmental footprint.

The Foron SP-WF range, which includes primary and ternary color grades, has been developed to fulfil the high colour wet fastness and performance requirements of sportswear manufacturers and brands. The core ternary colour grades enable deep shades at lower dyeing temperatures on sensitive polyester/elastane fabrics without causing excessive fiber damage, saving energy resources and meeting the high fastness demand of leading brand companies. When using these dyes, manufacturers can in many cases significantly reduce their consumption of time, energy, chemical, and water, as well as their CO2 emissions.

 

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.